Today: September 17, 2024
Today: September 17, 2024

Latest From Maggie Fick

Health|News

New Alzheimer's drug deemed too costly for UK's state-run health service

Alzheimer's patients in Britain's state-run health service are unlikely to get access to Eisai and Biogen's new Leqembi drug, after it was approved on Thursday by the

New Alzheimer's drug deemed too costly for UK's state-run health service
Business|Finance|Health

Novo Nordisk posts rare miss on sales of obesity drug Wegovy

Novo Nordisk on Wednesday trimmed its full-year profit outlook after reporting weaker-than-expected quarterly sales of its popular weight-loss drug Wegovy, stirring

Novo Nordisk posts rare miss on sales of obesity drug Wegovy
Business|Health

Novo owner backs Swiss biotech Asceneuron in $100 million round

Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy maker Novo Nordisk to fund

Novo owner backs Swiss biotech Asceneuron in $100 million round
Health|Science

Second malaria vaccine launched in Ivory Coast in new milestone

The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine programme using shots developed by the University of Oxford

Second malaria vaccine launched in Ivory Coast in new milestone
Health|Science

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows

Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows
Business

Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms

Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big

Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms
Business

Weight-loss drugs in spotlight as pharma services firms rush to snap up business

Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for

Weight-loss drugs in spotlight as pharma services firms rush to snap up business
Business

Weight-loss drugs fuel boom for firms that fill syringes

Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the

Weight-loss drugs fuel boom for firms that fill syringes
Health

Wegovy users have less kidney-related health problems, analysis of Novo study finds

Novo Nordisk's Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the

Wegovy users have less kidney-related health problems, analysis of Novo study finds
World

How well-off Brits still buy Ozempic online for weight loss

John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator.

How well-off Brits still buy Ozempic online for weight loss
Health|News|World

Main maternity hospital in Rafah stops admitting patients

The main maternity hospital in the Gaza Strip's crowded southern city of Rafah has stopped admitting patients, the United Nations Population Fund (UNFPA) said on

Main maternity hospital in Rafah stops admitting patients

Follow